Prediction of melanoma metastasis by the Shields index based on lymphatic vessel density
Open Access
- 17 May 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 10 (1), 208
- https://doi.org/10.1186/1471-2407-10-208
Abstract
Background Melanoma usually presents as an initial skin lesion without evidence of metastasis. A significant proportion of patients develop subsequent local, regional or distant metastasis, sometimes many years after the initial lesion was removed. The current most effective staging method to identify early regional metastasis is sentinel lymph node biopsy (SLNB), which is invasive, not without morbidity and, while improving staging, may not improve overall survival. Lymphatic density, Breslow's thickness and the presence or absence of lymphatic invasion combined has been proposed to be a prognostic index of metastasis, by Shields et al in a patient group. Methods Here we undertook a retrospective analysis of 102 malignant melanomas from patients with more than five years follow-up to evaluate the Shields' index and compare with existing indicators. Results The Shields' index accurately predicted outcome in 90% of patients with metastases and 84% without metastases. For these, the Shields index was more predictive than thickness or lymphatic density. Alternate lymphatic measurement (hot spot analysis) was also effective when combined into the Shields index in a cohort of 24 patients. Conclusions These results show the Shields index, a non-invasive analysis based on immunohistochemistry of lymphatics surrounding primary lesions that can accurately predict outcome, is a simple, useful prognostic tool in malignant melanoma.Keywords
This publication has 20 references indexed in Scilit:
- The Value of Sentinel Node Biopsy in Patients with Primary Cutaneous MelanomaDermatologic Surgery, 2008
- Sentinel Lymph Node Biopsy: An Alternate ViewDermatologic Surgery, 2008
- Impact of False-Negative Sentinel Lymph Node Biopsy on Survival in Patients with Cutaneous MelanomaAnnals of Surgical Oncology, 2007
- Tumor-Induced Sentinel Lymph Node Lymphangiogenesis and Increased Lymph Flow Precede Melanoma MetastasisThe American Journal of Pathology, 2007
- Chemokine-mediated migration of melanoma cells towards lymphatics – a mechanism contributing to metastasisOncogene, 2006
- VEGF-C–induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sitesBlood, 2006
- Sentinel-Node Biopsy or Nodal Observation in MelanomaThe New England Journal of Medicine, 2006
- Sentinel Node Biopsy for Early-Stage MelanomaAnnals of Surgery, 2005
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)JNCI Journal of the National Cancer Institute, 2005
- PC18 PERITUMOUR LYMPHATIC DENSITY (LD) IN METASTATIC MALIGNANT MELANOMA LIES WITHIN THE RANGE OF SUPERFICIAL DERMAL LD IN NORMAL HUMAN SKINMicrocirculation, 2004